#1 Clinical Trials Search in Europe

Piracetam

Piracetam, a nootropic drug, has been the subject of numerous clinical trials investigating its potential benefits across various medical conditions. This article delves into the use of piracetam in clinical research, examining its effects on cognitive function, neurological disorders, and other medical applications. We’ll explore the latest findings, potential benefits, and ongoing research efforts to better understand this intriguing compound.

Table of Contents

What is Piracetam?

Piracetam is a medication that belongs to a class of drugs known as nootropics, which are sometimes called “smart drugs” or cognitive enhancers. It is structurally related to GABA (gamma-aminobutyric acid), a neurotransmitter that helps calm brain activity[1]. Piracetam has been used clinically to treat a wide range of conditions, primarily those affecting brain function and cognition.

Medical Uses of Piracetam

Piracetam has been studied and used for various medical conditions, including:

  • Cognitive Impairment: It has been investigated for its potential to improve memory and cognitive function in people with mild cognitive impairment (MCI)[2].
  • Stroke Recovery: Piracetam has been studied for its potential to help patients recover from stroke, particularly in improving speech and language functions (aphasia) after an acute ischemic stroke[3].
  • Tardive Dyskinesia: This is a movement disorder that can be a side effect of long-term use of certain psychiatric medications. Piracetam has been investigated as a potential treatment[1].
  • Vertigo: Some studies have looked at piracetam’s effectiveness in treating vertigo, which is a sensation of spinning or dizziness[4].
  • Cocaine Addiction: Research has been conducted on piracetam’s potential role in treating cocaine addiction[5][6].
  • Diabetic Peripheral Neuropathy: This is a type of nerve damage that can occur in people with diabetes. Piracetam has been studied for its potential to help manage symptoms of this condition[7].

How Piracetam Works

Piracetam is believed to work in several ways to improve brain function:

  • Brain Energy Enhancement: It may help improve brain energy, especially under conditions of deficit such as hypoxia (low oxygen) or impaired brain circulation[1].
  • Neuroprotection: Piracetam may help protect brain cells from damage[1].
  • Neurotransmitter Modulation: It may influence the release of neurotransmitters, which are chemicals that help brain cells communicate[1].
  • Membrane Fluidity: Piracetam might improve the fluidity of cell membranes in the brain, which could enhance cognitive function[1].

Dosage and Administration

The dosage of piracetam can vary widely depending on the condition being treated and the individual patient. In clinical trials, doses have ranged from as low as 1.25 mg to as high as 24,000 mg per day[8][2]. It’s crucial to note that piracetam should only be taken under the guidance of a healthcare professional, who will determine the appropriate dosage based on your specific condition and needs.

Piracetam can be administered in various forms, including:

  • Oral tablets or capsules
  • Oral solution (liquid form)
  • Intravenous (IV) infusion (in hospital settings)

Potential Side Effects

While piracetam is generally considered to be a safe medication, like all drugs, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Dizziness
  • Nausea
  • Nervousness or anxiety
  • Sleep disturbances

It’s important to report any side effects to your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation.

Ongoing Research

Research on piracetam is ongoing, with scientists continuing to explore its potential benefits for various conditions. Some areas of current research include:

  • Post-Polio Syndrome: A study is investigating whether a combination of piracetam and L-carnitine could help relieve weakness, muscle fatigue, and muscle pain in people with post-polio syndrome[9].
  • Alzheimer’s Disease: Researchers are comparing the long-term use of piracetam with other cognitive enhancers in patients with Alzheimer’s disease[10].
  • Medication Adherence: A study is exploring whether very low doses of piracetam could be used as a marker to check if patients are taking their medications as prescribed[8].

It’s important to note that while these studies are promising, more research is needed to fully understand the benefits and risks of piracetam for these conditions. Always consult with your healthcare provider before starting or changing any medication regimen.

Aspect Details
Primary Uses in Trials Cognitive enhancement, neuroprotection, treatment of neurological disorders
Conditions Studied Mild cognitive impairment, diabetic peripheral neuropathy, tardive dyskinesia, cocaine addiction, aphasia after stroke, postpoliomyelitis syndrome
Administration Methods Oral tablets, intravenous infusions, oral solutions
Dosage Range 1.25 mg to 12 g per day, depending on the condition and study design
Trial Durations Varies from a few weeks to 12 months
Key Mechanisms Cerebral homeostatic normalization, neuroprotection, enhancement of brain energy
Safety Profile Generally considered safe, with ongoing monitoring for adverse events in trials
Outcome Measures Cognitive function tests, pain scales, quality of life assessments, neurological examinations

FAQ

  • What is piracetam and how does it work? Piracetam is a nootropic drug structurally related to GABA. It acts as a cerebral homeostatic normalizer, neuroprotectant, and brain integrative agent. Piracetam enhances brain energy, especially under deficit conditions, and preserves synaptic membrane and receptor structure.
  • What medical conditions are being studied with piracetam? Clinical trials are investigating piracetam for various conditions, including mild cognitive impairment, diabetic peripheral neuropathy, tardive dyskinesia, cocaine addiction, aphasia after stroke, and postpoliomyelitis syndrome.
  • How is piracetam administered in clinical trials? Piracetam is administered in various forms depending on the study, including oral tablets, intravenous infusions, and oral solutions. Dosages can range from low doses of 1.25 mg to high doses of 12 g per day, depending on the condition being treated and the study design.
  • Are there any side effects associated with piracetam use? While piracetam is generally considered safe, clinical trials monitor for potential side effects. Patients are educated about expected side effects and are required to report any adverse events. The safety and tolerability of piracetam are assessed throughout the studies.
  • How long do piracetam clinical trials typically last? The duration of piracetam clinical trials varies depending on the condition being studied and the research objectives. Some trials last for a few weeks, while others can extend up to 12 months to assess long-term effects and safety.

Ongoing Clinical Trials on Piracetam

  • Study on Sustained-Release Dexamphetamine and Piracetam for Patients with Moderate to Severe Cocaine Use Disorder and Opioid Dependence

    Recruiting

    1 1
    Investigated drugs:
    The Netherlands

Glossary

  • Nootropic: A type of drug or supplement that is believed to enhance cognitive function, particularly executive functions, memory, creativity, or motivation in healthy individuals.
  • GABA (Gamma-Aminobutyric Acid): The primary inhibitory neurotransmitter in the central nervous system, which plays a crucial role in reducing neuronal excitability throughout the nervous system.
  • Tardive Dyskinesia: A neurological disorder characterized by involuntary, repetitive body movements, often caused as a side effect of long-term use of certain psychiatric medications.
  • Aphasia: A language disorder caused by damage to specific brain regions, affecting a person's ability to communicate effectively through speech, writing, or comprehension.
  • Postpoliomyelitis Syndrome: A condition that affects polio survivors years after recovery from an initial acute attack of the poliomyelitis virus, characterized by slowly progressive muscle weakness, fatigue, and pain.
  • Neuroprotectant: A substance that protects nerve cells from damage, degeneration, or impairment of function.
  • Bioavailability: The proportion of a drug or substance that enters the circulation when introduced into the body and is able to have an active effect.
  • Extrapyramidal Symptoms: Movement disorders, such as tremors or muscle rigidity, that can occur as side effects of certain medications, particularly antipsychotic drugs.
  • Cognitive Function: Mental processes involved in gaining knowledge and comprehension, including thinking, knowing, remembering, judging, and problem-solving.
  • Placebo: A substance or treatment with no known medical benefits, used in clinical trials as a control to compare against the effects of the drug being tested.

References

  1. https://clinicaltrials.gov/study/NCT00190008
  2. https://clinicaltrials.gov/study/NCT00567060
  3. https://clinicaltrials.gov/study/NCT01883011
  4. https://clinicaltrials.gov/study/NCT01890538
  5. https://clinicaltrials.gov/study/NCT00000198
  6. https://clinicaltrials.gov/study/NCT00000199
  7. https://clinicaltrials.gov/study/NCT06479629
  8. https://clinicaltrials.gov/study/NCT05918341
  9. https://clinicaltrials.gov/study/NCT01549847
  10. https://clinicaltrials.gov/study/NCT01009476